Development Level

Tbio 6 | 11,445
Tchem 5 | 1,598
Tclin 3 | 613

IMPC Phenotype

abnormal behavior 1 | 298
decreased circulating chloride... 1 | 30
decreased total body fat amoun... 1 | 207
decreased vertical activity 1 | 208
hyperactivity 1 | 148
improved glucose tolerance 1 | 79
preweaning lethality, incomple... 1 | 499

Disease

Carcinoma 11 | 11,493
glioblastoma 7 | 5,792
medulloblastoma, large-cell 7 | 6,241
atypical teratoid / rhabdoid tumor 6 | 5,112
lung cancer 6 | 4,740
Kidney cancer 5 | 2,613
adult high grade glioma 5 | 3,801
ependymoma 5 | 4,679
lung carcinoma 5 | 2,843
osteosarcoma 5 | 7,950
ovarian cancer 5 | 8,520
primitive neuroectodermal tumor 5 | 3,035
psoriasis 5 | 6,694
Acquired metabolic disease 4 | 336
Astrocytoma, Pilocytic 4 | 3,081
Hypertension 4 | 396
astrocytic glioma 4 | 2,597
interstitial cystitis 4 | 2,312
intraductal papillary-mucinous adenoma (IPMA) 4 | 2,955
intraductal papillary-mucinous carcinoma (IPMC) 4 | 2,989
invasive ductal carcinoma 4 | 2,951
lung adenocarcinoma 4 | 2,716
non-small cell lung cancer 4 | 2,890
Bipolar Disorder 3 | 666
Schizophrenia 3 | 1,160
breast carcinoma 3 | 1,638
group 4 medulloblastoma 3 | 1,855
intraductal papillary-mucinous neoplasm (IPMN) 3 | 3,291
medulloblastoma 3 | 720
oligodendroglioma 3 | 2,850
pituitary cancer 3 | 1,972
Asthma 2 | 385
Autosomal recessive predisposition 2 | 1,442
Breast cancer 2 | 3,578
Cardiomyopathies 2 | 110
Depressive disorder 2 | 409
Hyperactive behavior 2 | 91
Hyperkinesis 2 | 32
Liver Cirrhosis, Experimental 2 | 769
Migraine 2 | 83
Mood Disorders 2 | 184
Nasal congestion 2 | 21
Osteoporosis 2 | 363
Pain 2 | 103
Rheumatoid arthritis 2 | 1,191
Sepsis 2 | 24
Skin cancer 2 | 469
Substance Withdrawal Syndrome 2 | 55
dermatomyositis 2 | 966
diabetes mellitus 2 | 1,728
facioscapulohumeral dystrophy 2 | 288
group 3 medulloblastoma 2 | 4,104
pancreatic cancer 2 | 2,398
pediatric high grade glioma 2 | 1,064
tuberculosis 2 | 2,010
ulcerative colitis 2 | 1,819
Acute conjunctivitis 1 | 4
Acute cystitis 1 | 35
Adenocarcinoma 1 | 122
Anorexia 1 | 43
Anxiety 1 | 136
Anxiety Disorders 1 | 38
Anxiety disease 1 | 113
Biliary Obstruction with Pruritus 1 | 1
Charcot-Marie-Tooth disease type 1A 1 | 11
Common cold 1 | 67
Cystinuria 1 | 18
Dilated pupil 1 | 6
Drug allergy 1 | 36
Familial idiopathic hypercalciuria 1 | 1
Fibrosis 1 | 44
Glomerulonephritis 1 | 46
Glycine encephalopathy 1 | 29
Hereditary neuropathy with liability to pressure palsies 1 | 9
Hypercalcemia 1 | 59
Hypercalciuria, Absorptive, 2 1 | 1
Hyperlipidemia 1 | 43
Hyperparathyroidism 1 | 48
Hypophosphatemia 1 | 40
Hypotension 1 | 82
Mammary Neoplasms, Animal 1 | 136
Meningoencephalitis 1 | 13
Osteomalacia 1 | 35
Panic disorder 1 | 61
Phaeochromocytoma 1 | 20
Psychoses, Substance-Induced 1 | 17
Pulmonary emphysema 1 | 48
Renal tubular acidosis 1 | 24
Respiratory Distress Syndrome, Adult 1 | 40
Rickets 1 | 49
Small Cell Lung Carcinoma 1 | 41
Small cell carcinoma of lung 1 | 45
Type 1 Diabetes Mellitus Treatment Adjunct 1 | 4
Type 2 Diabetes Mellitus Treatment Adjunct 1 | 7
Ventricular Dysfunction, Left 1 | 22
Vesicoureteral reflux 1 | 32
Weight Gain 1 | 100
Weight Loss 1 | 24
chronic kidney disease 1 | 90
idiopathic hypercalciuria 1 | 1

Tissue

Blood and immune system 14 | 16,909
Digestive Tract 14 | 17,369
Endocrine System 14 | 18,159
Female tissues 14 | 17,400
Liver and Pancreas 14 | 16,750
Male tissues 14 | 17,142
Skin and soft tissues 14 | 17,230
Urinary Tract 14 | 16,678
Cardiovascular System 13 | 15,192
Nervous System 13 | 16,725
Respiratory system 13 | 16,393

Target Family

Enzyme 8 | 4,145
GPCR 3 | 408
Non-IDG 3 | 12,091

GO Process

cAMP biosynthetic process 14 | 14
transcription, DNA-templated 1,742 | 1,742
regulation of transcription, D... 1,135 | 1,135
G-protein coupled receptor sig... 1,053 | 1,053
signal transduction 1,005 | 1,005
positive regulation of transcr... 932 | 932
negative regulation of transcr... 683 | 683
positive regulation of transcr... 529 | 529
apoptotic process 511 | 511
cell differentiation 511 | 511
negative regulation of transcr... 492 | 492
neutrophil degranulation 484 | 484
negative regulation of apoptot... 479 | 479
positive regulation of cell pr... 470 | 470
innate immune response 469 | 469
multicellular organism develop... 460 | 460
cell adhesion 458 | 458
immune response 426 | 426
viral process 405 | 405
negative regulation of cell pr... 398 | 398
spermatogenesis 389 | 389
intracellular signal transduct... 376 | 376
inflammatory response 373 | 373
cell proliferation 366 | 366
post-translational protein mod... 356 | 356
protein transport 348 | 348
protein ubiquitination 347 | 347
cell division 345 | 345
regulation of transcription fr... 345 | 345
protein phosphorylation 334 | 334
nervous system development 321 | 321
positive regulation of apoptot... 320 | 320
response to drug 303 | 303
cell-cell signaling 300 | 300
positive regulation of gene ex... 297 | 297
transcription from RNA polymer... 286 | 286
protein deubiquitination 271 | 271
cell cycle 268 | 268
regulation of immune response 259 | 259
transport 255 | 255
regulation of apoptotic proces... 250 | 250
MAPK cascade 242 | 242
cell surface receptor signalin... 239 | 239
mRNA splicing, via spliceosome 236 | 236
protein polyubiquitination 222 | 222
angiogenesis 220 | 220
chemical synaptic transmission 219 | 219
cellular response to DNA damag... 217 | 217
proteolysis 217 | 217
proteasome-mediated ubiquitin-... 210 | 210
adaptive immune response 209 | 209
intracellular protein transpor... 209 | 209
DNA repair 206 | 206
leukocyte migration 206 | 206
protein homooligomerization 206 | 206
rRNA processing 204 | 204
extracellular matrix organizat... 198 | 198
visual perception 198 | 198
positive regulation of ERK1 an... 194 | 194
cellular protein metabolic pro... 192 | 192
brain development 188 | 188
axon guidance 186 | 186
Fc-epsilon receptor signaling ... 182 | 182
keratinization 182 | 182
cell migration 181 | 181
defense response to virus 181 | 181
positive regulation of cell mi... 179 | 179
regulation of cell proliferati... 177 | 177
in utero embryonic development 176 | 176
Wnt signaling pathway 175 | 175
cilium assembly 175 | 175
blood coagulation 170 | 170
RNA splicing 169 | 169
translation 169 | 169
mRNA processing 168 | 168
protein autophosphorylation 168 | 168
aging 167 | 167
response to hypoxia 166 | 166
T cell receptor signaling path... 164 | 164
heart development 164 | 164
negative regulation of canonic... 164 | 164
positive regulation of I-kappa... 164 | 164
ubiquitin-dependent protein ca... 164 | 164
ER to Golgi vesicle-mediated t... 162 | 162
protein stabilization 160 | 160
response to lipopolysaccharide 160 | 160
transcription initiation from ... 160 | 160
defense response to bacterium 159 | 159
protein folding 159 | 159
sensory perception of smell 157 | 157
homophilic cell adhesion via p... 156 | 156
transmembrane transport 154 | 154
negative regulation of gene ex... 151 | 151
interferon-gamma-mediated sign... 150 | 150
receptor-mediated endocytosis 150 | 150
ion transmembrane transport 148 | 148
peptidyl-serine phosphorylatio... 148 | 148
positive regulation of protein... 148 | 148
antigen processing and present... 143 | 143
DNA replication 142 | 142
cell cycle arrest 142 | 142

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Adenylate cyclase type 10 ADCY10 Tchem Enzyme -3.13751 1324.4 108
Trace amine-associated receptor 1 TAAR1 Tclin GPCR -2.49444 308.8 117
Urocortin-2 UCN2 Tbio Non-IDG -2.05990 129.7 107
Adenylate cyclase type 6 ADCY6 Tchem Enzyme -2.05332 113.7 111
ADM ADM Tbio Non-IDG -3.27504 1889.0 381
Adenylate cyclase type 1 ADCY1 Tchem Enzyme -1.61657 45.3 134
Adenylate cyclase type 4 ADCY4 Tbio Enzyme -2.04603 107.6 156
Adenylate cyclase type 5 ADCY5 Tchem Enzyme -2.37306 236.5 103
Receptor activity-modifying protein 2 RAMP2 Tclin Non-IDG -1.88714 81.5 157
Adenylate cyclase type 3 ADCY3 Tbio Enzyme -2.31593 204.4 82